Prometheus Biosciences, Inc. (RXDX) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
01M2M4M5M6M8M9M10MQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Operating Expenses

Research And Development ExpensesGeneral And Administrative Expenses
08M15M22M30M38M45M52M60MQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023

EBITDA

EBITDA
-60M-52M-45M-37M-30M-22M-15M-7M1Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

EPS

Revenue Variation (%)

Revenue Variation
-80-2040100160220280340400Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
050100150200250300350400Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Revenue YoY Variation (%)

Revenue YoY Variation
-90-1658131205279352426500Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
0112225338450562675788900Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Price-to-Earning Ratio

P/E Ratio
-40-35-30-25-20-14-9-41Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Income Breakdown

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
02M5M8M10M12M15M18M20MQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
0918263544526170Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Free Cash Flow

Cash Flow to Debt Ratio

Cash At End Of Period
050M100M150M200M250M300M350M400MQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023
🏦 Balance Sheet
📈 Key Metrics